Cargando…

Molecular target therapy – towards curative regimen: a 20-year experience in the treatment of acute promyelocytic leukemia (APL) in the Shanghai Institute of Hematology

Detalles Bibliográficos
Autor principal: Shen, Zhi-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322486/
https://www.ncbi.nlm.nih.gov/pubmed/19558731
http://dx.doi.org/10.1186/1756-8722-2-S1-A1
_version_ 1782356390782697472
author Shen, Zhi-Xiang
author_facet Shen, Zhi-Xiang
author_sort Shen, Zhi-Xiang
collection PubMed
description
format Online
Article
Text
id pubmed-4322486
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43224862015-02-12 Molecular target therapy – towards curative regimen: a 20-year experience in the treatment of acute promyelocytic leukemia (APL) in the Shanghai Institute of Hematology Shen, Zhi-Xiang J Hematol Oncol Meeting Abstract BioMed Central 2009-06-26 /pmc/articles/PMC4322486/ /pubmed/19558731 http://dx.doi.org/10.1186/1756-8722-2-S1-A1 Text en Copyright © 2009 Shen; licensee BioMed Central Ltd.
spellingShingle Meeting Abstract
Shen, Zhi-Xiang
Molecular target therapy – towards curative regimen: a 20-year experience in the treatment of acute promyelocytic leukemia (APL) in the Shanghai Institute of Hematology
title Molecular target therapy – towards curative regimen: a 20-year experience in the treatment of acute promyelocytic leukemia (APL) in the Shanghai Institute of Hematology
title_full Molecular target therapy – towards curative regimen: a 20-year experience in the treatment of acute promyelocytic leukemia (APL) in the Shanghai Institute of Hematology
title_fullStr Molecular target therapy – towards curative regimen: a 20-year experience in the treatment of acute promyelocytic leukemia (APL) in the Shanghai Institute of Hematology
title_full_unstemmed Molecular target therapy – towards curative regimen: a 20-year experience in the treatment of acute promyelocytic leukemia (APL) in the Shanghai Institute of Hematology
title_short Molecular target therapy – towards curative regimen: a 20-year experience in the treatment of acute promyelocytic leukemia (APL) in the Shanghai Institute of Hematology
title_sort molecular target therapy – towards curative regimen: a 20-year experience in the treatment of acute promyelocytic leukemia (apl) in the shanghai institute of hematology
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322486/
https://www.ncbi.nlm.nih.gov/pubmed/19558731
http://dx.doi.org/10.1186/1756-8722-2-S1-A1
work_keys_str_mv AT shenzhixiang moleculartargettherapytowardscurativeregimena20yearexperienceinthetreatmentofacutepromyelocyticleukemiaaplintheshanghaiinstituteofhematology